BioSpace News Archive

Pharvaris (Nasdaq: PHVS), a clinical-stage company focused on the discovery and development of novel oral bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin-B2-receptor-mediated indications, today announced that Berndt Modig, chief executive officer and co-founder of Pharvaris, will participate in BioCapital Europe, to be held virtually on March 11, 2021.

Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced its operating and financial results for the fourth quarter and full-year ending December 31, 2020 and provided a corporate update.

Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Company management will participate in the 33 rd Annual ROTH Conference, which will be held virtually on March 15-17, 2021.

DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, today announced the treatment of the first patient in a Phase 1 dose-escalation and dose-expansion study of DNX-2440

Leading the way for more than 85 years, Beckman Coulter Life Sciences proudly announces the launch of its highly anticipated CytoFLEX SRT Benchtop Sorter-- the CytoFLEX that sorts, and features expanded laser and color options for use in labs of all sizes

LLS clinical trials will use the FDA-cleared BioSticker to evaluate correlation of vital signs and select symptoms to treatment [04-March-2021] DENVER , March 4, 2021 /PRNewswire/ -- BioIntelliSense, Inc. , a continuous health monitoring and clinical intelligence company, today announced the company has entered into a strategic partnership with The Leukemia & L

CVS Health announced it will invest $12.4 million to build 60 new units of affordable housing in south Phoenix and expand the company’s no-cost preventive health screening program, Project Health, in the greater Phoenix area as part of CVS Health’s commitment to provide $600 million over five years to address racial inequity and social determinants of health in Black communities.

Alkermes plc (Nasdaq: ALKS) announced today that it will hold a virtual Investor Day on Thursday, March 25, 2021 , beginning at 9:00 a.m. ET ( 1:00 p.m. GMT ).

CytRx Corporation has announced the appointment of Christophe Bourdon as its new Chief Executive Officer, effective as of April 1, 2021.

Walgreens broadens digital health marketplace with 15 new or expanded national and local providers offering cancer screening, diabetes management, vision and mental health services